Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CRMD
CRMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRMD News
CorMedix to Participate in Two Major Healthcare Conferences
May 15 2026
Newsfilter
CorMedix Q1 2026 Earnings Call Insights
May 14 2026
seekingalpha
CorMedix Reports Strong Q1 Earnings, Raises 2026 Revenue Guidance
May 14 2026
stocktwits
CorMedix Q1 Earnings Exceed Expectations
May 14 2026
seekingalpha
CorMedix Scheduled to Announce Q1 Earnings
May 13 2026
seekingalpha
CorMedix to Report Q1 2026 Financial Results on May 14
May 05 2026
Newsfilter
Positive Trial Results for Rezzayo Antifungal Drug
Apr 27 2026
stocktwits
CorMedix Reports Positive Phase III Results for REZZAYO in Fungal Disease Prevention
Apr 27 2026
NASDAQ.COM
CorMedix Announces Positive Phase III Results for REZZAYO
Apr 27 2026
Newsfilter
CorMedix to Participate in Needham Conference
Apr 07 2026
Newsfilter
CorMedix Reports 2025 Financial Results and Guidance
Mar 06 2026
NASDAQ.COM
CorMedix Q4 2025 Earnings Call Insights
Mar 05 2026
seekingalpha
CorMedix Q4 2025 Earnings Misses Expectations
Mar 05 2026
seekingalpha
CorMedix Reports Q4 Revenue Surge Amid Mixed Earnings
Mar 05 2026
stocktwits
CORMEDIX Q4 OPERATING EXPENSES REVISED TO USD 48.182 MILLION
Mar 05 2026
moomoo
CorMedix Q4 Earnings Beat Expectations, Share Buyback Plan Approved
Mar 05 2026
seekingalpha
Show More News
